Giuseppa Penna

1.2k total citations
31 papers, 904 citations indexed

About

Giuseppa Penna is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Giuseppa Penna has authored 31 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Giuseppa Penna's work include Multiple Myeloma Research and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Giuseppa Penna is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Giuseppa Penna collaborates with scholars based in Italy, United States and Russia. Giuseppa Penna's co-authors include Alessandro Allegra, Caterina Musolino, Andrea Alonci, Demetrio Gerace, Annamaria Petrungaro, Salvatore Campo, Sabina Russo, Vanessa Innao, Antonino Cannavò and Giacomo Bellomo and has published in prestigious journals such as Antioxidants, Critical Reviews in Oncology/Hematology and Cellular Immunology.

In The Last Decade

Giuseppa Penna

30 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppa Penna Italy 16 499 265 253 214 126 31 904
Haifeng Zhao China 19 358 0.7× 253 1.0× 172 0.7× 236 1.1× 85 0.7× 83 1.0k
Saeid Shahrabi Iran 17 323 0.6× 155 0.6× 156 0.6× 273 1.3× 212 1.7× 49 872
Jia Wei China 20 321 0.6× 91 0.3× 444 1.8× 137 0.6× 73 0.6× 69 1.1k
Shudao Xiong China 22 614 1.2× 469 1.8× 503 2.0× 155 0.7× 67 0.5× 49 1.4k
Hongsheng Zhou China 20 576 1.2× 150 0.6× 314 1.2× 751 3.5× 397 3.2× 127 1.6k
Ke Liu China 17 414 0.8× 261 1.0× 176 0.7× 97 0.5× 26 0.2× 48 1.1k
Jinxia Zhao China 18 294 0.6× 102 0.4× 204 0.8× 137 0.6× 43 0.3× 78 985
Elsie Oppermann Germany 19 304 0.6× 115 0.4× 211 0.8× 46 0.2× 83 0.7× 58 997
Hong‐Wei Gao Taiwan 18 298 0.6× 127 0.5× 180 0.7× 44 0.2× 55 0.4× 85 963

Countries citing papers authored by Giuseppa Penna

Since Specialization
Citations

This map shows the geographic impact of Giuseppa Penna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppa Penna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppa Penna more than expected).

Fields of papers citing papers by Giuseppa Penna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppa Penna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppa Penna. The network helps show where Giuseppa Penna may publish in the future.

Co-authorship network of co-authors of Giuseppa Penna

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppa Penna. A scholar is included among the top collaborators of Giuseppa Penna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppa Penna. Giuseppa Penna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gangemi, Sebastiano, et al.. (2024). Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis. Antioxidants. 13(4). 475–475. 11 indexed citations
3.
Allegra, Alessandro, Vanessa Innao, Giuseppa Penna, et al.. (2017). Telomerase and telomere biology in hematological diseases: A new therapeutic target. Leukemia Research. 56. 60–74. 20 indexed citations
4.
Allegra, Alessandro, Giuseppa Penna, Vanessa Innao, et al.. (2015). Vaccination of multiple myeloma: Current strategies and future prospects. Critical Reviews in Oncology/Hematology. 96(2). 339–354. 23 indexed citations
5.
Allegra, Alessandro, Andrea Alonci, Giuseppa Penna, et al.. (2014). The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets. Cancer Investigation. 32(9). 470–495. 66 indexed citations
6.
Martino, Massimo, Maurizio Postorino, Giuseppe Messina, et al.. (2013). Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs. Clinical Lymphoma Myeloma & Leukemia. 14(2). 148–154. 12 indexed citations
7.
Musolino, Caterina, Alessandro Allegra, Antonella Saija, et al.. (2012). Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia. Clinical Biochemistry. 45(16-17). 1439–1443. 37 indexed citations
8.
Gangemi, Sebastiano, Alessandro Allegra, Andrea Alonci, et al.. (2012). Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. Inflammation Research. 61(10). 1063–1067. 56 indexed citations
9.
Gangemi, Sebastiano, Alessandro Allegra, Elisabetta Pace, et al.. (2012). Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia. Cellular Immunology. 278(1-2). 91–94. 12 indexed citations
10.
Allegra, Alessandro, Andrea Alonci, Salvatore Campo, et al.. (2012). Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). International Journal of Oncology. 41(6). 1897–1912. 299 indexed citations
11.
Allegra, Alessandro, Emanuela Sant’Antonio, Giuseppa Penna, et al.. (2010). Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors. European Journal Of Haematology. 86(2). 93–110. 43 indexed citations
12.
Penna, Giuseppa, Alessandro Allegra, Andrea Alonci, et al.. (2010). MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. Medical Oncology. 28(4). 1549–1554. 25 indexed citations
13.
Allegra, Alessandro, Andrea Alonci, Giacomo Bellomo, et al.. (2010). Serum levels of Interleukin‐16 in a multiple myeloma patient with cutaneous involvement. International Journal of Dermatology. 49(4). 435–437. 4 indexed citations
14.
Allegra, Alessandro, Andrea Alonci, Giuseppa Penna, et al.. (2010). Bisphosphonates Induce Apoptosis of Circulating Endothelial Cells in Multiple Myeloma Patients and in Subjects with Bisphosphonate-Induced Osteonecrosis of the Jaws. Acta Haematologica. 124(2). 79–85. 38 indexed citations
15.
Musolino, Caterina, Emanuela Sant’Antonio, Giuseppa Penna, et al.. (2010). Epigenetic therapy in myelodysplastic syndromes. European Journal Of Haematology. 84(6). 463–473. 26 indexed citations
16.
Allegra, Alessandro, et al.. (2009). Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. Medical Oncology. 27(3). 912–914. 6 indexed citations
17.
18.
Alonci, Andrea, Alessandro Allegra, Giacomo Bellomo, et al.. (2009). Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. Medical Oncology. 27(4). 1336–1339. 2 indexed citations
19.
Alonci, Andrea, Alessandro Allegra, Giacomo Bellomo, et al.. (2008). Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. Hematological Oncology. 26(4). 235–239. 29 indexed citations
20.
Morabito, Fortunato, R.A. Merendino, Giuseppa Penna, et al.. (2005). The CX3C Chemokine Fractalkine (CX3CL1) Is Detectable in Serum of B Cell Chronic Lymphocytic Leukemia Patients with Lymph Node Involvement. Acta Haematologica. 113(2). 152–154. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haifeng Zhao Breakdown of academic impact, for papers by Saeid Shahrabi Breakdown of academic impact, for papers by Jia Wei Breakdown of academic impact, for papers by Shudao Xiong Breakdown of academic impact, for papers by Hongsheng Zhou Breakdown of academic impact, for papers by Ke Liu Breakdown of academic impact, for papers by Jinxia Zhao Breakdown of academic impact, for papers by Elsie Oppermann Breakdown of academic impact, for papers by Hong‐Wei Gao
Rankless by CCL
2026